Cart
sales@molnova.com
HFY-4A
CAS No. 2094810-82-7
HFY-4A( —— )
Catalog No. M37090 CAS No. 2094810-82-7
HFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 73 | In Stock |
|
| 5MG | 103 | In Stock |
|
| 10MG | 154 | In Stock |
|
| 25MG | 247 | In Stock |
|
| 50MG | 361 | In Stock |
|
| 100MG | 601 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2115 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHFY-4A
-
NoteResearch use only, not for human use.
-
Brief DescriptionHFY-4A is a novel HDAC inhibitor.HFY-4A has antitumour activity and has shown antiproliferative activity in breast cancer cells.
-
DescriptionHFY-4A is a HDAC inhibitor. HFY-4A inhibits breast cancer cell proliferation, migration, and invasion, and induces cell apoptosis. HFY-4A induces immunogenic cell death (ICD). HFY-4A inhibits tumor growth in breast cancer xenograft mouse models.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | HDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2094810-82-7
-
Formula Weight333.38
-
Molecular FormulaC20H19N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NCC1=CC=C(/C=C/C(NO)=O)C=C1)C2=NC3=C(C=C2)C=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yin Y, et al. The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer. Toxicol Appl Pharmacol. 2023 Nov 1;478:116698.?
molnova catalog
related products
-
K145 hydrochloride
K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 μM and Ki of 6.4 μM. K145 hydrochloride can induce apoptosis and has strong antitumor activity.
-
Ecteinascidin 770
A tetrahydroisoquinoline alkaloid with potent anticaner activities; shows cytotoxicity against human cell lines HCT116, QG56, and DU145 with IC50 of 0.60, 2.4, and 0.81 nM, respectively.
-
Snail/HDAC-IN-1
Snail/HDAC-IN-1 is a Snail/HDAC inhibitor with antimicrobial and anticancer activity, known to reduce Snail protein expression and induce apoptosis, making it useful for the study of solid tumors.
